Deborah Morosini

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Laurent Chardonnet, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deborah Morosini:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prelude Therapeutics Inc EVP, Chief of Clinical Affairs Common Stock 444 $1,674 $3.77 15 Dec 2021 Direct
Prelude Therapeutics Inc EVP, Chief of Clinical Affairs Employee Stock Option (right to buy) 90,000 15 Feb 2022 Direct

Insider Reports Filed by Deborah Morosini

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRLD Prelude Therapeutics Inc 15 Feb 2022 1 $0 4 EVP, Chief of Clinical Affairs 17 Feb 2022, 18:08
PRLD Prelude Therapeutics Inc 15 Dec 2021 6 -$37,368 4 EVP, Chief of Clinical Affairs 17 Dec 2021, 16:20
PRLD Prelude Therapeutics Inc 16 Nov 2021 4 -$87,081 4 EVP, Chief of Clinical Affairs 18 Nov 2021, 17:42
PRLD Prelude Therapeutics Inc 20 Jul 2021 1 $0 4 EVP, Chief of Clinical Affairs 22 Jul 2021, 18:14